Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
Victor G VogelThe University of Pittsburgh Cancer Institute, Magee-Womens Hospital, Pittsburgh, PA, USAAbstract: Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) that has antiestrogenic effects on breast and endometrial tissue and estrogenic effects on bone, lipid metabolis...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2008
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/1e041e0247bf4427836baa6118c6155e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|